Patent · US Expired

Leukaemia inhibitory factor

US6261548A · kind A · utility

2Cited by

3References

6Claims

0Family size

Assignee

AMRAD Corporation Limited · AU

Inventors

David Gearing · Melbourne, AU
Nicholas Martin Gough · Melbourne, AU
Douglas Hilton · Melbourne, AU
Julie Ann King · Melbourne, AU
Donald Metcalf · Melbourne, AU
Edouard Collins Nice · Melbourne, AU
Nicos A. Nicola · Melbourne, AU
Richard J. Simpson · Melbourne, AU
Tracy Willson · Melbourne, AU

Key dates

Filing date	Apr 21, 1997
Grant date	Jul 17, 2001
Priority date	—
Expiry date	Apr 21, 2017

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2740/13043
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides isolated DNA molecules encoding human and murine LIF and methods of producing LIF by the expression of the isolated DNA and suitable host cells. The invention further provides human and murine LIF polypeptides, pharmaceutical compositions containing LIF, and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.